ID   PER-163
AC   CVCL_W977
DR   Wikidata; Q54947176
RX   PubMed=2720661;
RX   PubMed=3472651;
RX   PubMed=7540895;
DI   NCIt; C9140; Childhood B acute lymphoblastic leukemia
DI   ORDO; Orphanet_99860; Precursor B-cell acute lymphoblastic leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_W976 ! PER-145
OI   CVCL_W978 ! PER-164
SX   Male
CA   Cancer cell line
DT   Created: 17-07-14; Last updated: 21-03-23; Version: 6
//
RX   PubMed=2720661;
RA   Kees U.R., Ford J., Dawson V.M., Piall E.M., Aherne G.W.;
RT   "Development of resistance to 1-beta-D-arabinofuranosylcytosine after
RT   high-dose treatment in childhood lymphoblastic leukemia: analysis of
RT   resistance mechanism in established cell lines.";
RL   Cancer Res. 49:3015-3019(1989).
//
RX   PubMed=3472651;
RA   Kees U.R.;
RT   "Resistance to 1-beta-D-arabinofuranosylcytosine after high-dose
RT   treatment childhood lymphoblastic leukemia: isolation of a drug
RT   resistant and a sensitive cell line.";
RL   Cancer Res. 47:3088-3091(1987).
//
RX   PubMed=7540895; DOI=10.1097/00001813-199504000-00015;
RA   Kees U.R., Avramis V.I.;
RT   "Biochemical pharmacology and DNA methylation studies of arabinosyl
RT   5-azacytidine and 5,6-dihydro-5-azacytidine in two human leukemia
RT   cell lines PER-145 and PER-163.";
RL   Anticancer Drugs 6:303-310(1995).
//